| [1] |
HE Lucen, ZHOU Guizhi, ZHANG Fan, LIU Hong.
Tofacitinib in the treatment of acquired reactive perforating collagenosis: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 348-352.
|
| [2] |
YANG Xiaoqi, CHENG Yanru, SUN Yuanhang, ZHOU Guizhi, WANG Guangjin.
Tofacitinib treatment for discoid lupus erythematosus: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 357-360.
|
| [3] |
JIANG Xiaoxue, CHEN Ruolin, WANG Yuxi, SHI Zhiyuan, LIU Xinyi, CAO Yan.
Advances in targeted therapy for acral vitiligo
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(5): 373-377.
|
| [4] |
LI Xiaoxian, CAO Nan, CHEN Xi, LIU Guoyan.
Update of small molecule drugs and targeted therapies for moderate-to-severe alopecia areata
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(4): 305-310.
|
| [5] |
HUO Jianli, ZHANG Shaoguang, WANG Liu.
Efficacy and safety analysis of tofacitinib combined with 308 nm excimer laser in the treatment of vitiligo
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 163-167.
|
| [6] |
LIU Jiayun, GAO Guomin, LI Xiaojin, FAN Huiping, WANG Xing, ZHANG Dong, MA Weiyuan.
Analysis of clinical efficacy of tofacitinib in the treatment of papulopustular rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 168-171.
|
| [7] |
HUA Lingyun, XIA Rushan.
Application of JAK inhibitors in rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 67-70.
|
| [8] |
QU Peng, LIU Yongxia, WANG Guangjin.
Tofacitinib in the treatment of refractory rosacea: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(9): 682-684.
|
| [9] |
ZHOU Meng, SUO Panpan, LIU Baoguo, LYU Chao, WANG Xin, MIAO Guoying.
Efficacy of biological agents or small molecular targeted drugs in the treatment of 6 cases with refractory pityriasis rubra pilaris
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 583-586.
|
| [10] |
CAO Shan, ZHAO Qing, HUAI Pengcheng, ZHANG Furen.
Tofacitinib monotherapy successfully treated pemphigus vulgaris: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(7): 522-523.
|
| [11] |
LIU Mingyue, TAN Shuhui, ZHANG Zhe, NIE Zhenhua.
Update of the treatment for bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(7): 538-542.
|
| [12] |
XIA Fanxi, YU Meiwen.
Update on treatment of leprosy reaction
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(5): 377-383.
|
| [13] |
YUAN Mingzhu, LI Ruyi, SUN Yi, ZHANG Wen.
Severe alopecia areata unresponsive to baricitinib susessfully treated with upadacitinib: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(4): 283-287.
|
| [14] |
FU Fanghui, MA Lei, LI Yuan, HU Haiyou, ZHANG Xi, GAO Yu, FU Wenjing.
Acquired reactive perforating collagenosis successfully treated with tofacitinib: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(3): 198-201.
|
| [15] |
WEI Ting, ZHANG Fan, LIU Jianxin, TIAN Hongqing.
Actinic prurigo successfully treated with tofacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(12): 893-895.
|
